The purpose of this study is to compare infection rates when patients, elected for primary or aseptic revision THA / TKA, have a single intravenous antibiotic dose versus one single intravenous antibiotic dose in combination with intra-articular antibiotics. This is a prospective, randomized clinical survey on selected outcome measurements on 1834 subjects who will be recruited in a period of about 2 years.
Group A: patients receiving single dose of IV cefazolin 10-60 minutes before incision. Group B: patients receiving a single dose of IV cefazolin 10-60 minutes before incision + a single dose of intra-articular vancomycin powder before articulation (hip or knee) closure.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
1,832
All patients include in the study will undergo a lowerlimb arthroplasty, primary or revision
Hopital Sacré-Coeur de Montreal
Montreal, Quebec, Canada
Acute Infection rate
Infection rate after after lowerlimb arthroplasty depending on the antibiotic molecule that was given
Time frame: 3 months
Long-term infection rate
Infection rate after after lowerlimb arthroplasty depending on the antibiotic molecule that was given
Time frame: 2 years
Risk factor
Infection rate in patients with risk factors depending on the antibiotic molecule that was given
Time frame: 2 years
Primary vs revision
Infection rate in primary versus revisions surgery depending on the antibiotic molecule that was given
Time frame: 2 years
Surgery time
Infection rate according to surgery time depending on the antibiotic molecule that was given
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.